Johns Hopkins University at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Johns Hopkins University brings 2 presentations to AMP 2026 in Seattle. Its program covers practical approaches to putting long-read sequencing to work in the clinic and the use of menin inhibitors in acute myeloid leukaemia.
| Organization | AMP 2026 Attendance |
|---|---|
Johns Hopkins University Baltimore, MD | |
Private research university in Baltimore with medical school work on cancer genetics, cell-free DNA and molecular diagnostics. | Talk Fri, Nov 13 1:15pm–2:00pm Menin Inhibitor Use in Acute Myeloid Leukemia Current evidence for menin inhibition in acute myeloid leukemia, approved and investigational drugs, and residual disease monitoring. Talk Sat, Nov 14 3:00pm–3:30pm Putting Long-Read Sequencing to Work: Practical Approaches for the Clinic Practical long-read sequencing for structural variants across large cohorts, targeted enrichment and difficult clinical samples. |
Instantly find 20 buyers from Johns Hopkins University
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction